文献速递糖尿病

加拿大与美国长期1型糖尿病的糖尿病照护差异:一项横断面比较

Diabetes Care Disparities in Long-standing Type 1 Diabetes in Canada and the U.S.: A Cross-sectional Comparison.
PubMed 文献 · Diabetes Care · 2017-11-08

比较加拿大长期1型糖尿病研究与美国Joslin Medalist研究中病程≥50年1型糖尿病患者的照护与生活质量。加拿大人HbA1c更高、生活质量优良比例更低、冠脉疾病和胰岛素泵使用更少;调整后差异仍存在,其他并发症率相似。

要点

  • 加拿大人HbA1c均值7.53% vs 美国人7.22%(P<0.0001)。
  • 生活质量「优良」比例加拿大人36.9% vs 美国人48.7%(P=0.0002)。
  • 冠脉疾病29.7% vs 41.2%、胰岛素泵使用43.3% vs 55.6%,加拿大均更低。

核心结论

  • 除冠脉疾病外,两国其他并发症率相似,但加拿大人HbA1c更高、生活质量更低、胰岛素泵使用更少,需进一步研究原因。

研究设计与样本

  • 横断面比较,数据来自加拿大长期1型糖尿病研究(2013-2016年收集)与Joslin Medalist研究(2005-2011年收集)中相同的调查问卷。
  • 共纳入361名加拿大人和668名美国人,年龄均值65.78岁(SD 8.67)vs 66.38岁(7.66),P=0.27;糖尿病病程中位数53.00年(IQR 51.00, 58.00)vs 53.00年(51.00, 57.00),P=0.51。
  • 实验室值和眼科检查分别由加拿大临床照护医生和Joslin Clinic完成;肾病、冠脉疾病和外周动脉疾病为自我报告;神经病变定义为密歇根神经病变筛查量表问卷部分评分≥3;增殖性视网膜病变来自眼科检查记录。

主要发现

  • 加拿大人HbA1c均值7.53%(SD 1.03)[59 mmol/mol] vs 美国人7.22%(0.98)[55 mmol/mol],P<0.0001。
  • 生活质量「优良」比例加拿大人36.9% vs 美国人48.7%,P=0.0002。
  • 冠脉疾病比例加拿大人29.7% vs 美国人41.2%,P=0.0003;胰岛素泵使用比例加拿大人43.3% vs 美国人55.6%,P=0.0002。
  • 调整年龄、性别、冠脉疾病、外周动脉疾病、教育及相关预设变量后,加拿大人较美国人HbA1c高0.28%(P=0.0004);生活质量更高、冠脉疾病、胰岛素泵使用的比值比分别为0.68(95%CI 0.51, 0.90)、0.46(0.31, 0.68)、0.71(0.52, 0.96)。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: To assess national differences in diabetes care and quality of life (QOL) between individuals with long-standing type 1 diabetes (≥50 years) in Canada and the U.S. RESEARCH DESIGN AND METHODS: Cross-sectional data from identical surveys administered in the Canadian Study of Longevity in Diabetes and the Joslin Medalist Study, collected in 2013-2016 and 2005-2011, respectively, were compared. Laboratory values and ophthalmic examination were completed by clinical care physicians for Canadians and the Joslin Clinic for Americans. Univariate comparisons and multivariable regression for HbA1c, QOL, insulin pump use, and coronary artery disease (CAD) were performed. Nephropathy, CAD, and peripheral arterial disease (PAD) were self-reported; neuropathy was defined by a Michigan Neuropathy Screening Instrument (Questionnaire component) score ≥3, and proliferative retinopathy was documented from ophthalmic examination. QOL was self-reported on an ordinal scale. RESULTS: Three hundred sixty-one Canadians and 668 Americans had similar ages (mean 65.78 years [SD 8.67] vs. 66.38 years [7.66], P = 0.27) and durations of diabetes (median 53.00 years [interquartile range 51.00, 58.00] vs. 53.00 years [51.00, 57.00], P = 0.51). Canadians had higher HbA1c (mean 7.53% [SD 1.03] [59 mmol/mol] vs. 7.22% [0.98] [55 mmol/mol], P < 0.0001), lower QOL (36.9% vs. 48.7% with "excellent" QOL, P = 0.0002), and less CAD (29.7% vs. 41.2%, P = 0.0003) and insulin pump use (43.3% vs. 55.6%, P = 0.0002). Other complication rates were similar. Residual differences for Canadians compared with Americans remained after adjustment for age, sex, CAD, PAD, education, and relevant a priori selected variables: 0.28% higher HbA1c (P = 0.0004); and odds ratios of 0.68 (95% CI 0.51, 0.90), 0.46 (0.31, 0.68), and 0.71 (0.52, 0.96) for higher QOL, CAD, and insulin pump use, respectively. CONCLUSIONS: Although Canadians and Americans have similar rates of complications other than CAD, further research is required to understand why Canadians have higher HbA1c levels, lower QOL, and less insulin pump use.

来源:Diabetes Care,查看原文。版权归原作者所有。

引用

  1. Weisman A, Lovblom LE, Keenan HA, et al. Diabetes Care Disparities in Long-standing Type 1 Diabetes in Canada and the U.S.: A Cross-sectional Comparison. Diabetes Care. 2017. PMID: 29118059. doi:10.2337/dc17-1074

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。